Skip to main content

Peer Review reports

From: Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study

Original Submission
19 Aug 2016 Submitted Original manuscript
2 Sep 2016 Author responded Author comments - Lin Shen
Resubmission - Version 2
2 Sep 2016 Submitted Manuscript version 2
9 Jan 2017 Reviewed Reviewer Report - Arjun Kalvala
6 Feb 2017 Reviewed Reviewer Report - Linara Gabitova
28 Feb 2017 Author responded Author comments - Lin Shen
Resubmission - Version 3
28 Feb 2017 Submitted Manuscript version 3
11 Mar 2017 Reviewed Reviewer Report - Linara Gabitova
18 Mar 2017 Reviewed Reviewer Report - Roberto Passera
10 Apr 2017 Author responded Author comments - Lin Shen
Resubmission - Version 4
10 Apr 2017 Submitted Manuscript version 4
11 Apr 2017 Reviewed Reviewer Report - Roberto Passera
12 Jul 2017 Author responded Author comments - Ruihua Xu
Resubmission - Version 5
12 Jul 2017 Submitted Manuscript version 5
18 Jul 2017 Author responded Author comments - Ruihua Xu
Resubmission - Version 6
18 Jul 2017 Submitted Manuscript version 6
29 Aug 2017 Author responded Author comments - Ruihua Xu
Resubmission - Version 7
29 Aug 2017 Submitted Manuscript version 7
3 Nov 2017 Author responded Author comments - Ruihua Xu
Resubmission - Version 8
3 Nov 2017 Submitted Manuscript version 8
Publishing
8 Dec 2017 Editorially accepted
22 Dec 2017 Article published 10.1186/s12885-017-3887-z

You can find further information about peer review here.

Back to article page